Four medical professionals with the nonprofit Doctors for America write that Dr. Mehmet Oz’s conflicts of interest and support of therapies not grounded in science make him a poor choice to

Oz's confirmation would advance the Republicans' plan to hand even more of traditional public Medicare over to insurers like UnitedHealth.

The wealth of Mehmet Oz, MD, the celebrity heart surgeon nominated by President Trump to lead CMS, has swelled in part from for-profit healthcare companies over which he'd wield significant power if confirmed, according to a newly filed government ethics ...

Adopting this approach, CMS could make achieving a certain threshold of successful treatment of hypertension the dominant measure for the quality assessment of Medicare Advantage plans, and link that measure to bonuses. CMS could also penalize those achieving less than 50 percent control.

Dr. Mehmet Oz, a former television personality and Senate candidate, is still likely to win confirmation to head the Centers for Medicare and Medicaid Services.

Mehmet Oz is pledging to divest from a broad portfolio of health care stocks if he is confirmed as President Trump’s pick to lead the Centers for Medicare and Medicaid Services.